(Q44124071)

English

Bullous skin lesions following infliximab infusion in a patient with rheumatoid arthritis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Bullous skin lesions following infliximab infusion in a patient with rheumatoid arthritis (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

1 reference

based on heuristic

inferred from title

author name string

Peter D Kent

1

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

John M Davis

2

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Mark D P Davis

3

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Eric L Matteson

4

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

publication date

1 August 2002

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Arthritis & Rheumatology

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

46

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

2257-8; author reply 2259

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Anti-tumor necrosis factor therapies

1 reference

https://api.crossref.org/works/10.1002%2FART.10348

21 January 2018

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

1 reference

https://api.crossref.org/works/10.1002%2FART.10348

21 January 2018

Long term safety of infliximab

1 reference

https://api.crossref.org/works/10.1002%2FART.10348

21 January 2018

Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1002%2FART.10348

21 January 2018

Review article: safety of infliximab in clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FART.10348

21 January 2018

Identifiers

10.1002/ART.10348

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44124071&oldid=2106831116"